Mission Pharmacal announced the launch of CitraNatal basic, an over-the-counter (OTC) prenatal vitamin for pre-pregnancy nutritional support.
The FDA has granted Orphan Drug designation to AC-201 for the treatment of epidermolysis bullosa (EB).
The FDA has accepted for filing the New Drug Application (NDA) for aripiprazole lauroxil, a once-monthly injectable atypical antipsychotic for the treatment of schizophrenia.
The FDA has accepted for filing the NDA for empagliflozin plus immediate-release metformin HCl fixed-dose combination for the treatment of adults with type 2 diabetes.
A retrospective study identifies a potential link between NSAID use and breast cancer recurrence and overweight and obese women.